Name | methyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate |
---|---|
Synonyms |
1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid, 4-chloro-, methyl ester
METHYL 4-CHLORO-7-AZAINDOLE-5-CARBOXYLATE 4-Chloro-7-azaindole-5-carboxylic acid methyl ester |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 340.1±37.0 °C at 760 mmHg |
Molecular Formula | C9H7ClN2O2 |
Molecular Weight | 210.617 |
Flash Point | 159.5±26.5 °C |
Exact Mass | 210.019608 |
PSA | 54.98000 |
LogP | 2.79 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.657 |
Storage condition | 2-8°C |
Hazard Codes | Xi |
---|---|
HS Code | 2933990090 |
~% 951625-93-7 |
Literature: Helicon Therapeutics, Inc. Patent: US2012/95016 A1, 2012 ; Location in patent: Page/Page column 24 ; |
~% 951625-93-7 |
Literature: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.; HOPKINS, Brian, T.; SCOTT, Daniel; CONLON, Patrick; JENKINS, Tracy, J.; POWELL, Noel; GUAN, Bing; CURERVO, Julio, H.; WANG, Deping; TAVERAS, Art Patent: WO2012/58645 A1, 2012 ; WO 2012/058645 A1 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |